Related Experiment Videos
[Generalized mastocytosis; to be considered following resuscitation]
P H Groeneveld1, C D Stehouwer, R J Strack van Schijndel
1Academisch Ziekenhuis Vrije Universiteit, afd. Acute Inwendige Geneeskunde, Amsterdam.
Abstract:
This case report describes a male patient aged 44 with recurrent hypotensive shock and severe pulmonary obstruction. The diagnosis of systemic mastocytosis was suggested by the presence of small pigmented maculae (urticaria pigmentosa) and intolerance to NSAIDs. The diagnosis was confirmed by microscopic investigation of the pigmented maculae and bone. The patient was advised to avoid certain foods and drugs and has so far been free of symptoms. In patients with hypotensive shock and (or) severe pulmonary obstruction without a clear cause, systemic mastocytosis should be included in the differential diagnosis.
Insights
Systemic mastocytosis can cause severe hypotension and pulmonary issues. Early diagnosis through skin findings and NSAID intolerance is crucial for prompt management and symptom relief.
Area of Science:
- Hematology
- Dermatology
- Internal Medicine
Background:
- Systemic mastocytosis (SM) is a rare disorder characterized by abnormal mast cell accumulation.
- Unexplained hypotensive shock and severe pulmonary obstruction can be presenting symptoms of SM.
Observation:
- A 44-year-old male presented with recurrent hypotensive shock and severe pulmonary obstruction.
- Physical examination revealed small pigmented maculae (urticaria pigmentosa) and a history of NSAID intolerance.
Findings:
- Microscopic examination of pigmented maculae and bone confirmed the diagnosis of systemic mastocytosis.
- The patient's symptoms resolved after avoiding specific foods and drugs.
Implications:
- Systemic mastocytosis should be considered in the differential diagnosis of patients with unexplained hypotensive shock or severe pulmonary obstruction.
- Identifying and avoiding triggers is essential for managing systemic mastocytosis and preventing life-threatening events.